Latest Breaking News On - Prnewswire johnson consumer health - Page 1 : comparemela.com

Johnson & Johnson Consumer Health Presents New Data on Skincare for Cancer Patients at the American Academy of Dermatology VMX 2021 New Study Results Indicate a Daily Avena Sativa (Oat) Skincare Regimen Significantly Improves Itch and Dry Skin in Adults Undergoing Systemic Cancer Treatments News provided by Share this article Share this article SKILLMAN, N.J., April 23, 2021 /PRNewswire/ Johnson & Johnson Consumer Health today presented findings from one of the first clinical studies examining a daily skincare regimen as adjunctive therapy for cancer patients at the American Academy of Dermatology (AAD) Virtual Meeting Experience (VMX) 2021. The study shows a daily Avena Sativa (Oat) skincare regimen provided a significant improvement in xerosis and pruritus (dry skin and itch) for adult patients undergoing systemic oncology treatments, indicating Aveeno Restorative Skin Therapy is safe and effective for the management of mild-to-moderate itch and/or dry skin related to system

United statesGeorgios stamatasCaroline tillettA johnson consumer healthAmerican academy of dermatologyJohnson consumer healthPrnewswire johnson consumer healthJanssen pharmaceutical companies of johnsonAmerican academyVirtual meeting experienceAvena sativaAveeno restorative skin therapyJohnson consumerAvena sativa skincare regimenRestorative skin therapy sulfate free body washRestorative skin therapy oat repairing cream